Fmoc-Nalpha-methyl-O-t-butyl-L-tyrosine

We are Fmoc-Nalpha-methyl-O-t-butyl-L-tyrosine CAS:133373-24-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 133373-24-7
Product Name: Fmoc-Nalpha-methyl-O-t-butyl-L-tyrosine
Other Name:
Fmoc-Nalpha-methyl-O-t-butyl-L-tyrosine
Fmoc-N-Me-Tyr(tBu)-OH
O-tert-Butyl-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-N-methyl-L-tyrosine
(2S)-2-[9H-fluoren-9-ylmethoxycarbonyl(methyl)amino]-3-[4-[(2-methylpropan-2-yl)oxy]phenyl]propanoic acid
N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-N-methyl-O-(2-methyl-2-propanyl)-L-tyrosine
 
Density: 1.2±0.1 g/cm3
Boiling Point: 638.9±55.0 °C at 760 mmHg
Molecular Formula: C29H31NO5
Molecular Weight: 473.560
Flash Point: 340.2±31.5 °C
Exact Mass: 473.220215
PSA: 76.07000
LogP: 7.04
Vapour Pressure: 0.0±2.0 mmHg at 25°C
Index of Refraction: 1.598
Storage condition: Store at 0-5°C
 
Specification
Appearance: White powder
Assay: ≥98.0%
 
Application
Amino Acid Derivatives. Be used as pharmaceutical intermediates.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

Fmoc-Nalpha-methyl-O-t-butyl-L-tyrosine


Related News: Zhejiang Tianyu Co., Ltd .: It is mainly engaged in the research and development and production of sartan-type APIs and intermediates. It has serialized sartan-type APIs and intermediate products, and has accumulated rich chemical synthesis technology. It has strong technical advantages and Scale advantage.10-ACETOXY-1-CLORODECANO CAS:51309-11-6 Though many of the remedies have been in use for hundreds of years, critics argue that there is no verifiable scientific evidence to support their supposed benefits.913614-18-3 Multinational drugmakers usually cut the price of drugs when they go off-patent and face competition from generic versions, but such price drops were slow to happen in China, partially because many local drugmakers were unable to develop high-quality generic drugs to compete with off-patent branded drugs.18-corona-6 CAS:17455-13-9 Multinational drugmakers usually cut the price of drugs when they go off-patent and face competition from generic versions, but such price drops were slow to happen in China, partially because many local drugmakers were unable to develop high-quality generic drugs to compete with off-patent branded drugs.Under the strict supervision of environmental protection, it has helped the API industry to continuously optimize its product structure, realize industrial upgrading, and transition to the development of high-end APIs.

Related Products
Product Name
8-Bromo-1-octene View Details
(2-bromo-4-fluorophenyl)methanol View Details
5-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]furan-2-carbaldehyde View Details
2-(2-amino-1,3-thiazol-4-yl)acetic acid manufacturer 1-Ethyl-3-methylimidazolium thiocyanate manufacturer 2-Methylacetoacetanilide manufacturer Vespertilin manufacturer 1,3-difluoro-5-nitrobenzene manufacturer